Search

everythinglearnresearchcommunity

for

Search:↓

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

In 2005, men used finasteride mainly to treat an enlarged prostate.

The treatment effectively promoted hair growth with minimal side effects.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

BPH medications may increase the risk of self-harm and depression, especially in the first 18 months.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Finasteride lowers prostate cancer risk but may increase high-grade tumors and sexual side effects.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Certain drugs that block specific enzymes can help treat prostate diseases.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Sonirid Duo effectively treats benign prostatic hyperplasia.

Dutasteride and finasteride affect different cell types differently.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Topical finasteride may be safer than oral finasteride, but more research is needed.

Methods accurately measure tamsulosin hydrochloride and finasteride in combined dosages.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

The formulation with oleic acid may be better for treating male pattern baldness.

Men with better urinary symptoms have a lower risk of death.